Bibliometric analysis on exploitation of biogenic gold and silver nanoparticles in breast, ovarian and cervical cancer therapy

Multifunctional nanoparticles are being formulated to overcome the side effects associated with anticancer drugs as well as conventional drug delivery systems. Cancer therapy has gained the advancement due to various pragmatic approaches with better treatment outcomes. The metal nanostructures such...

Full description

Bibliographic Details
Main Authors: Meena Bhandari, Seema Raj, Ashwani Kumar, Dilraj Preet Kaur
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.1035769/full
_version_ 1797979200211124224
author Meena Bhandari
Seema Raj
Ashwani Kumar
Dilraj Preet Kaur
author_facet Meena Bhandari
Seema Raj
Ashwani Kumar
Dilraj Preet Kaur
author_sort Meena Bhandari
collection DOAJ
description Multifunctional nanoparticles are being formulated to overcome the side effects associated with anticancer drugs as well as conventional drug delivery systems. Cancer therapy has gained the advancement due to various pragmatic approaches with better treatment outcomes. The metal nanostructures such as gold and silver nanoparticles accessible via eco-friendly method provide amazing characteristics in the field of diagnosis and therapy towards cancer diseases. The environmental friendly approach has been proposed as a substitute to minimize the use of hazardous compounds associated in chemical synthesis of nanoparticles. In this attempt, researchers have used various microbes, and plant-based agents as reducing agents. In the last 2 decades various papers have been published emphasizing the benefits of the eco-friendly approach and advantages over the traditional method in the cancer therapy. Despite of various reports and published research papers, eco-based nanoparticles do not seem to find a way to clinical translation for cancer treatment. Present review enumerates the bibliometric data on biogenic silver and gold nanoparticles from Clarivate Analytics Web of Science (WoS) and Scopus for the duration 2010 to 2022 for cancer treatment with a special emphasis on breast, ovarian and cervical cancer. Furthermore, this review covers the recent advances in this area of research and also highlights the obstacles in the journey of biogenic nanodrug from clinic to market.
first_indexed 2024-04-11T05:35:13Z
format Article
id doaj.art-e26a3ef5a6fd4771a5c9b02e5b5cbb1f
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-11T05:35:13Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-e26a3ef5a6fd4771a5c9b02e5b5cbb1f2022-12-22T13:54:49ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-12-011310.3389/fphar.2022.10357691035769Bibliometric analysis on exploitation of biogenic gold and silver nanoparticles in breast, ovarian and cervical cancer therapyMeena Bhandari0Seema Raj1Ashwani Kumar2Dilraj Preet Kaur3Department of Chemistry, School of Basic and Applied Sciences, K.R Mangalam University, Gurugram, IndiaDepartment of Chemistry, School of Basic and Applied Sciences, K.R Mangalam University, Gurugram, IndiaDepartment of Computer Sciences, School of Engineering and Technology, K.R Mangalam University, Gurugram, IndiaDepartment of Physics, School of Basic and Applied Sciences, K.R Mangalam University, Gurugram, IndiaMultifunctional nanoparticles are being formulated to overcome the side effects associated with anticancer drugs as well as conventional drug delivery systems. Cancer therapy has gained the advancement due to various pragmatic approaches with better treatment outcomes. The metal nanostructures such as gold and silver nanoparticles accessible via eco-friendly method provide amazing characteristics in the field of diagnosis and therapy towards cancer diseases. The environmental friendly approach has been proposed as a substitute to minimize the use of hazardous compounds associated in chemical synthesis of nanoparticles. In this attempt, researchers have used various microbes, and plant-based agents as reducing agents. In the last 2 decades various papers have been published emphasizing the benefits of the eco-friendly approach and advantages over the traditional method in the cancer therapy. Despite of various reports and published research papers, eco-based nanoparticles do not seem to find a way to clinical translation for cancer treatment. Present review enumerates the bibliometric data on biogenic silver and gold nanoparticles from Clarivate Analytics Web of Science (WoS) and Scopus for the duration 2010 to 2022 for cancer treatment with a special emphasis on breast, ovarian and cervical cancer. Furthermore, this review covers the recent advances in this area of research and also highlights the obstacles in the journey of biogenic nanodrug from clinic to market.https://www.frontiersin.org/articles/10.3389/fphar.2022.1035769/fullbiogenicsilver nanoparticlesgold nanoparticlescancer therapybibliometric analysis
spellingShingle Meena Bhandari
Seema Raj
Ashwani Kumar
Dilraj Preet Kaur
Bibliometric analysis on exploitation of biogenic gold and silver nanoparticles in breast, ovarian and cervical cancer therapy
Frontiers in Pharmacology
biogenic
silver nanoparticles
gold nanoparticles
cancer therapy
bibliometric analysis
title Bibliometric analysis on exploitation of biogenic gold and silver nanoparticles in breast, ovarian and cervical cancer therapy
title_full Bibliometric analysis on exploitation of biogenic gold and silver nanoparticles in breast, ovarian and cervical cancer therapy
title_fullStr Bibliometric analysis on exploitation of biogenic gold and silver nanoparticles in breast, ovarian and cervical cancer therapy
title_full_unstemmed Bibliometric analysis on exploitation of biogenic gold and silver nanoparticles in breast, ovarian and cervical cancer therapy
title_short Bibliometric analysis on exploitation of biogenic gold and silver nanoparticles in breast, ovarian and cervical cancer therapy
title_sort bibliometric analysis on exploitation of biogenic gold and silver nanoparticles in breast ovarian and cervical cancer therapy
topic biogenic
silver nanoparticles
gold nanoparticles
cancer therapy
bibliometric analysis
url https://www.frontiersin.org/articles/10.3389/fphar.2022.1035769/full
work_keys_str_mv AT meenabhandari bibliometricanalysisonexploitationofbiogenicgoldandsilvernanoparticlesinbreastovarianandcervicalcancertherapy
AT seemaraj bibliometricanalysisonexploitationofbiogenicgoldandsilvernanoparticlesinbreastovarianandcervicalcancertherapy
AT ashwanikumar bibliometricanalysisonexploitationofbiogenicgoldandsilvernanoparticlesinbreastovarianandcervicalcancertherapy
AT dilrajpreetkaur bibliometricanalysisonexploitationofbiogenicgoldandsilvernanoparticlesinbreastovarianandcervicalcancertherapy